What is Pathpoint?
Pathpoint operates as a fully-digital Excess and Surplus (E&S) brokerage. By integrating advanced technology with comprehensive services, Pathpoint empowers agents with instant, bindable quotes from a curated selection of best-in-class E&S carriers. This digital-first model streamlines the traditionally complex E&S placement process, offering efficiency and accessibility to insurance professionals seeking specialized coverage solutions.
How much funding has Pathpoint raised?
Pathpoint has raised a total of $42.5M across 2 funding rounds:
Series A
$30M
Series A
$12.5M
Series A (2021): $30M with participation from Hiscox, Chubb, Caffeinated Capital, Founders Fund, and SciFi VC
Series A (2023): $12.5M led by Caffeinated Capital
Key Investors in Pathpoint
Caffeinated Capital
Caffeinated Capital is a thesis and stage agnostic firm that typically partners with founders at the inception stage and invests throughout the company's lifecycle, with a notable focus on insurtech.
Hiscox
Hiscox Ltd. is an Anglo-Bermudan insurance provider specializing in niche areas of the market, offering property and casualty insurance for companies and high-net-worth individuals.
Chubb
Chubb Limited is a global insurance provider offering a wide range of property and casualty, specialty, and life insurance products to businesses and individuals worldwide.
What's next for Pathpoint?
The recent major strategic investment positions Pathpoint for accelerated expansion and further technological development. This capital infusion is expected to fuel enhancements in its digital platform, broaden its carrier partnerships, and potentially expand its market reach. As an insurtech firm focused on modernizing E&S brokerage, Pathpoint is poised to leverage this financing to solidify its competitive advantage and drive innovation within the specialty insurance landscape.
See full Pathpoint company page
